These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 8744011)
1. Simultaneous 3D NMR spectroscopy of fluorine and phosphorus in human liver during 5-fluorouracil chemotherapy. Li CW; Gonen O Magn Reson Med; 1996 Jun; 35(6):841-7. PubMed ID: 8744011 [TBL] [Abstract][Full Text] [Related]
2. Simultaneous 3D NMR spectroscopy of proton-decoupled fluorine and phosphorus in human liver during 5-fluorouracil chemotherapy. Gonen O; Murphy-Boesch J; Li CW; Padavic-Shaller K; Negendank WG; Brown TR Magn Reson Med; 1997 Feb; 37(2):164-9. PubMed ID: 9001138 [TBL] [Abstract][Full Text] [Related]
3. Proton-decoupled 19F spectroscopy of 5-FU catabolites in human liver. Murphy-Boesch J; Li CW; He L; Padavic-Shaller KA; Negendank W; Brown TR Magn Reson Med; 1997 Mar; 37(3):321-6. PubMed ID: 9055218 [TBL] [Abstract][Full Text] [Related]
4. Pre-treatment energy status of primary rat tumours as the best predictor of response to 5-fluorouracil chemotherapy: a magnetic resonance spectroscopy study in vivo. Lemaire LP; McSheehy PM; Griffiths JR Cancer Chemother Pharmacol; 1998; 42(3):201-9. PubMed ID: 9685055 [TBL] [Abstract][Full Text] [Related]
5. Quantitation of 5-fluorouracil catabolism in human liver in vivo by three-dimensional localized 19F magnetic resonance spectroscopy. Li CW; Negendank WG; Padavic-Shaller KA; O'Dwyer PJ; Murphy-Boesch J; Brown TR Clin Cancer Res; 1996 Feb; 2(2):339-45. PubMed ID: 9816177 [TBL] [Abstract][Full Text] [Related]
6. Fluorine-19 or phosphorus-31 NMR spectroscopy: a suitable analytical technique for quantitative in vitro metabolic studies of fluorinated or phosphorylated drugs. Martino R; Gilard V; Desmoulin F; Malet-Martino M J Pharm Biomed Anal; 2005 Aug; 38(5):871-91. PubMed ID: 16087049 [TBL] [Abstract][Full Text] [Related]
7. Optimization of localized 19F magnetic resonance spectroscopy for the detection of fluorinated drugs in the human liver. Klomp DW; Van Laarhoven HW; Kentgens AP; Heerschap A Magn Reson Med; 2003 Aug; 50(2):303-8. PubMed ID: 12876706 [TBL] [Abstract][Full Text] [Related]
8. Quantitative 19F MR spectroscopy at 3 T to detect heterogeneous capecitabine metabolism in human liver. Klomp D; van Laarhoven H; Scheenen T; Kamm Y; Heerschap A NMR Biomed; 2007 Aug; 20(5):485-92. PubMed ID: 17131325 [TBL] [Abstract][Full Text] [Related]
9. Fluoropyrimidine chemotherapy in a rat model: comparison of fluorouracil metabolite profiles determined by high-field 19F-NMR spectroscopy of tissues ex vivo with therapy response and toxicity for locoregional vs systemic infusion protocols. Lutz NW; Naser-Hijazi B; Koroma S; Berger MR; Hull WE NMR Biomed; 2004 May; 17(3):101-31. PubMed ID: 15137037 [TBL] [Abstract][Full Text] [Related]
10. pH dependence of 5-fluorouracil uptake observed by in vivo 31P and 19F nuclear magnetic resonance spectroscopy. Guerquin-Kern JL; Leteurtre F; Croisy A; Lhoste JM Cancer Res; 1991 Oct; 51(20):5770-3. PubMed ID: 1913695 [TBL] [Abstract][Full Text] [Related]
11. Fluorine nuclear magnetic resonance, a privileged tool for metabolic studies of fluoropyrimidine drugs. Martino R; Malet-Martino M; Gilard V Curr Drug Metab; 2000 Nov; 1(3):271-303. PubMed ID: 11465049 [TBL] [Abstract][Full Text] [Related]
12. Heteronuclear multivoxel spectroscopy of in vivo human brain: two-dimensional proton interleaved with three-dimensional 1H-decoupled phosphorus chemical shift imaging. Arias-Mendoza F; Javaid T; Stoyanova R; Brown TR; Gonen O NMR Biomed; 1996 May; 9(3):105-13. PubMed ID: 8892396 [TBL] [Abstract][Full Text] [Related]
13. Multinuclear MR investigation of the metabolic response of the murine RIF-1 tumor to 5-fluorouracil chemotherapy. Sijens PE; Baldwin NJ; Ng TC Magn Reson Med; 1991 Jun; 19(2):373-85. PubMed ID: 1908937 [TBL] [Abstract][Full Text] [Related]
14. A preliminary study for clinical pharmacokinetics of oral fluorine anticancer medicines using the commercial MRI system 19F-MRS. Ikehira H; Girard F; Obata T; Ito H; Yoshitomi H; Miyazaki M; Nakajima N; Kamei H; Kanazawa Y; Takano H; Ito H; Tanada S; Sasaki Y Br J Radiol; 1999 Jun; 72(858):584-9. PubMed ID: 10560341 [TBL] [Abstract][Full Text] [Related]
15. Molar quantitation of hepatic metabolites in vivo in proton-decoupled, nuclear Overhauser effect enhanced 31P NMR spectra localized by three-dimensional chemical shift imaging. Li CW; Negendank WG; Murphy-Boesch J; Padavic-Shaller K; Brown TR NMR Biomed; 1996 Jun; 9(4):141-55. PubMed ID: 9015801 [TBL] [Abstract][Full Text] [Related]
16. Can we use 1H MRS shimming values to obtain 31P spectra? Wu RH; Guo G; Zhang YP; Tran H; terBrugge K; Mikulis D Conf Proc IEEE Eng Med Biol Soc; 2006; 2006():1873-6. PubMed ID: 17946076 [TBL] [Abstract][Full Text] [Related]
17. Hepatic intracellular pH in vivo using F-quene 1 and 19F NMR spectroscopy. Beech JS; Iles RA Magn Reson Med; 1991 Jun; 19(2):386-92. PubMed ID: 1881327 [TBL] [Abstract][Full Text] [Related]
18. Solving problems fluorine 19F with NMR spectroscopy. Gonet B Med Sci Monit; 2001; 7(3):489-95. PubMed ID: 11386031 [TBL] [Abstract][Full Text] [Related]
19. Superiority of hepatic arterial infusion in preventing catabolism of 5-FU compared with portal vein infusion revealed by an in vivo 19F NMR study. Okuno K; Hirai N; Lee YS; Tarabar D; Ueno H; Yasutomi M Cancer Chemother Pharmacol; 1998; 42(4):341-4. PubMed ID: 9744781 [TBL] [Abstract][Full Text] [Related]
20. Fluorine nuclear magnetic resonance spectroscopy of human biofluids in the field of metabolic studies of anticancer and antifungal fluoropyrimidine drugs. Malet-Martino M; Gilard V; Desmoulin F; Martino R Clin Chim Acta; 2006 Apr; 366(1-2):61-73. PubMed ID: 16337167 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]